human use
of the Fixed Dose Combination (FDC) of the formulations
Aceclofenac + Paracetamol + Rabeprazol (hereafter referred to as 'the
said ... said drug combines the dosage of
Aceclofenac 100 mg, Paracetamol 325 mg and Rabeprazole 10 mg.
Petitioner no. 2 is the manufacturer of the said
distribution for human use of Fixed Dose
Combination (FDC) Drug of Etodolac + Paracetamol.
2. As the basic challenge in all the petitions ... 10098/2018, the petitioners manufacture FDC of S(+) Etodolac +
Paracetamol and therefore, while challenging the Impugned Notification,
as an alternative relief, they also seek
anti-inflammatory and analgesic medicines in the form of Diclofenac Sodium and Paracetamol tablets, injections and gel which are sold under the trade DICLOMOL ... taken the trade mark from the generic words Diclofenac Sodium and PARACETAMOL which is basic medicinal product, first 5 letters are from Diclofenac and last
1181/2003 Page 1 of 14
the plaintiffs for paracetamol tablets. The defendants are stated to be using
the mark „Effer-PARAMAX‟ for dissolvable paracetamol ... were restrained by the exparte order dated 28.5.2003 from
manufacturing and selling paracetamol tablets under the trademarks of the
plaintiffs and which order has been
review of safety of Nimesulide and rationality of its combination formulations with Paracetamol etc. had been taken up by the Expert Committee (a Sub Committee ... recommended the use of Nimesulide Along with other drugs like ibuprofen and paracetamol for controlling fever in adults as well as children. The criteria
polythene weighed approximately 5.48
Gms. which polythene was found to contain paracetamol, caffeine
and Monoacetyle Morphine, and it was thus submitted on behalf ... laboratory in the instant case it was found to contain
paracetamol, caffeine and monoacetyle morphine in view of the
deposition dated 18.05.2016 of Dr. Lingaraj
products of the Plaintiff sold under the brand "ULTRAMOL" are
paracetamol preparations in different dosage forms. The grievance of the
Plaintiff ... ULTRAMOL" in different dosage forms of the
same medicine, i.e., paracetamol.
CS(COMM) 240/2022 Page 1 of 19
Signature Not Verified
Digitally
highly distinctive Trade Dress for its product
'SUMO Nimesulide and Paracetamol' Tablets and has been extensively
using the same till date ... ZUMO'
being used for the product 'ZUMO Nimesulide and Paracetamol' tablets.
The Defendants have employed a nearly identical trade dress and have
drug. The said
mark has the active ingredient of „Camylofin Dihydrochloride with
Paracetamol‟. The said mark was originally stated to be owned by
Khandelwal Laboratories ... stated to be marketing
the drug containing „Camylofin Dihydrochloride with Paracetamol‟ in the
form of Tablets under the brand name „AMAFORTEN‟ which is similar
that this
drug is an anti-inflammatory preparation, being a combination of paracetamol and
ibuprofen. Section 29(1) of Trademarks Act, to the extent ... drugs. The drug of the
plaintiff is a combination of Diclofenac Sodium, Paracetamol and Chlorzoxazone,
CS(OS) 104/2011 Page 4 of 9
whereas
